Celator Pharmaceuticals, Inc.
(NASDAQ : CPXX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
1.48%131.000.6%$1120.95m
MRKMerck & Co., Inc.
0.62%76.070.6%$1110.44m
PFEPfizer Inc.
0.21%42.560.9%$1102.75m
BMYBristol-Myers Squibb Company
1.47%50.331.4%$992.79m
ABBVAbbVie, Inc.
2.97%89.792.2%$652.57m
LLYEli Lilly and Company
-1.90%116.901.0%$592.82m
NVSNovartis AG Sponsored ADR
0.42%89.000.2%$193.64m
AZNAstraZeneca PLC Sponsored ADR
0.72%36.551.3%$191.88m
GSKGlaxoSmithKline plc Sponsored ADR
0.21%39.060.2%$137.25m
NVONovo Nordisk A/S Sponsored ADR Class B
0.83%48.050.1%$71.34m
SNYSanofi Sponsored ADR
-1.36%41.480.2%$39.34m
LCILannett Company, Inc.
2.14%7.6537.0%$12.00m
AKTXAkari Therapeutics Plc Sponsored ADR
-5.21%1.821.7%$0.05m
EPIXESSA Pharma Inc
1.76%3.850.1%$0.03m

Company Profile

Celator Pharmaceuticals, Inc. is a clinical-stage company, which engages in the research and development of biopharmaceutical products. It intends to provide chemotherapies and molecularly targeted agents to deliver anti-cancer activity and enhance treatment outcomes for cancer patients. It operates under the CombiPlex platform. Its products include VYXEOS, CPX-1, and CPX-8. The company was founded by Lawrence David Mayer and Marcel B. Bally in 1999 and is headquartered in Ewing, NJ.